Precigen Inc (PGEN)
Bausch&Lomb Corp (BLCO)
New Form 8-K - Bausch & Lomb Corp Filed: 2025-08-18 AccNo: 0001860742-25-000019 Size: 460 KB Item 1.02: Termination of a Material Definitive Agreement Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: …
Syndax Pharmaceuticals Inc (SNDX)
Structure Therapeutics Inc (GPCR)
Precipio Inc (PRPO)
Beyond Air (XAIR)
X4 Pharmaceuticals Inc. (XFOR)
Bausch&Lomb Corp (BLCO)
Bausch + Lomb Announces Board Changes
Vascular Biogenics Ltd. (was rebranded to Notable Labs Ltd (NASDAQ: NTBL) on 17/10/2023 (VBLT)
Accelerate Diagnostics Inc (AXDX)
REGENXBIO Inc (RGNX)
REGENXBIO Announces FDA Review Extension of BLA for RGX-121 to Treat Patients with MPS II
Nutex Health Inc (NUTX)
Nutex Health Inc. (NUTX) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Celularity Inc. (CELUW)
REGENXBIO Announces FDA Review Extension of BLA for RGX-121 to Treat Patients with MPS II
Accelerate Diagnostics Inc (AXDX)
New Form 8-K - Accelerate Diagnostics, Inc Filed: 2025-08-18 AccNo: 0001104659-25-079855 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 1.03: Bankruptcy or Receivership Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits